Navigation Links
SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings

GREAT NECK, N.Y., Sept. 23 /PRNewswire/ -- Scarguard Labs, LLC, announced achieving the combined ranking of the #2 branded scar product and the fastest growing scar product in the category according to Information Resources, Inc.'s data ending August 8, 2010.

Scarguard MD dollar sales are up 49.5% over the prior year for the four week period ending August 8, 2010. Scarguard MD is also ranked the #2 branded scar product based on dollar sales for the same four week period.

"We are extremely pleased with the most recent consumption results showing the Scarguard MD brand outpacing all other scar brands in dollar sales growth," said Joel Studin, MD, Chief Executive Officer. This is a result of our 2010 advertising campaign supported by Scarguard's extensive retail distribution and the fact that Scarguard, unlike some of its competitors, actually is effective in helping to prevent scar tissue and reducing old scar tissue.* It is important for the consumer to know which products can really help them improve the way they look, and Scarguard MD has been proven in the medical literature and has now sold more than two million units.

About Scarguard Labs, LLC

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors, mass merchants, and major grocery chains throughout the United States. Scarguard has multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development. For more information, please visit our website at

*Based on independent clinical studies, available by request.

SOURCE Scarguard Labs, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
2. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
3. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
4. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
5. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
6. GeoVax Labs, Inc. Provides Clinical Studies Update
7. GeoVax Labs, Inc. Announces Resignation of Director
8. GeoVax Labs, Inc. Announces First Quarter Financial Results
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
10. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
11. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):